Demographic and clinical characteristics of the oestradiol and placebo groups
| Variable | Oestradiol (n = 17) | Placebo (n = 17) | p Value |
|---|---|---|---|
| Values are mean (SD) or n (%). | |||
| ACE, angiotensin converting enzyme. | |||
| Age (years) | 57.7 (4.0) | 59.5 (3.0) | NS |
| Race | |||
| White | 14 (82.4%) | 3 (17.7%) | NS |
| Black | 14 (82.4%) | 3 (17.7%) | NS |
| Menopause age (years) | 48.7 (4.6) | 49.3 (2.4) | NS |
| Menopause time (years) | 8.59 (6.8) | 10.18 (3.5) | NS |
| Menopause type† | |||
| Natural | 14 (82.4%) | 12 (70.6%) | NS |
| Surgical | 3 (17.7%) | 5 (29.4%) | NS |
| Diabetes | 4 (23.5%) | 5 (29.4%) | NS |
| Treatment | |||
| ACE inhibitor | 13 (76.5%) | 17 (100%) | NS |
| Diuretic | 14 (82.4%) | 9 (52.9%) | NS |
| α-Methyldopa | 3 (17.7%) | 4 (23.5%) | NS |
| Systemic arterial hypertension time (years) | 14 (9) | 18 (6) | NS |